Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocol.

Schwab, Simon; Sidler, Daniel; Haidar, Fadi; Kuhn, Christian; Schaub, Stefan; Koller, Michael; Mellac, Katell; Stürzinger, Ueli; Tischhauser, Bruno; Binet, Isabelle; Golshayan, Déla; Müller, Thomas; Elmer, Andreas; Franscini, Nicola; Krügel, Nathalie; Fehr, Thomas; Immer, Franz (2023). Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocol. Diagnostic and prognostic research, 7(1), p. 6. BioMed Central 10.1186/s41512-022-00139-5

Preview

Text s41512-022-00139-5.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview

BACKGROUND

Many potential prognostic factors for predicting kidney transplantation outcomes have been identified. However, in Switzerland, no widely accepted prognostic model or risk score for transplantation outcomes is being routinely used in clinical practice yet. We aim to develop three prediction models for the prognosis of graft survival, quality of life, and graft function following transplantation in Switzerland.

METHODS

The clinical kidney prediction models (KIDMO) are developed with data from a national multi-center cohort study (Swiss Transplant Cohort Study; STCS) and the Swiss Organ Allocation System (SOAS). The primary outcome is the kidney graft survival (with death of recipient as competing risk); the secondary outcomes are the quality of life (patient-reported health status) at 12 months and estimated glomerular filtration rate (eGFR) slope. Organ donor, transplantation, and recipient-related clinical information will be used as predictors at the time of organ allocation. We will use a Fine & Gray subdistribution model and linear mixed-effects models for the primary and the two secondary outcomes, respectively. Model optimism, calibration, discrimination, and heterogeneity between transplant centres will be assessed using bootstrapping, internal-external cross-validation, and methods from meta-analysis.

DISCUSSION

Thorough evaluation of the existing risk scores for the kidney graft survival or patient-reported outcomes has been lacking in the Swiss transplant setting. In order to be useful in clinical practice, a prognostic score needs to be valid, reliable, clinically relevant, and preferably integrated into the decision-making process to improve long-term patient outcomes and support informed decisions for clinicians and their patients. The state-of-the-art methodology by taking into account competing risks and variable selection using expert knowledge is applied to data from a nationwide prospective multi-center cohort study. Ideally, healthcare providers together with patients can predetermine the risk they are willing to accept from a deceased-donor kidney, with graft survival, quality of life, and graft function estimates available for their consideration.

STUDY REGISTRATION

Open Science Framework ID: z6mvj.

Interest & Impact

Downloads

57 since deposited on 07 Mar 2023
21 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item